Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Sandoz Inc., priced at $2.1134 per ML under NDC 00781718670. Its NADAC has been published 227 times since Jul 20, 2022.

FDA first approved this application on Apr 4, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

Brimonidine Tartrate and Timolol Maleate
$2.1134per ML

Strength

2; 5 mg/mL; mg/mL

Manufacturer

Sandoz Inc.

NDC

00781718670

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091087

FDA Approved

4/4/2022

TE Code

AB

On Market Since

4/13/2022

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 227 times since Jul 20, 2022, and over the history we have for it it has declined 91.3%. The table below summarizes its recorded NADAC range and movement.

Current price$2.1134 per ML
All-time high$32.9940 (Sep 14, 2022)
All-time low$1.9993 (Oct 21, 2026)
52-week high$2.8127
52-week low$1.9993
Median price$9.4084
Average price$11.9720
Largest weekly change+56.9% (May 22, 2024)
Weeks tracked227
Tracking sinceJul 20, 2022

Price History

1W

+5.7%

1M

-1.8%

3M

-14.1%

6M

-10.8%

1Y

-24.9%

3Y

-84.6%

5Y

N/A

All

-91.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Sandoz Inc., is $2.1134 per ML (NDC 00781718670), effective Nov 18, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 91.3%. It has been tracked across 227 weekly CMS publications since Jul 20, 2022.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since Jul 20, 2022, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $1.9993 (Oct 21, 2026) to a high of $32.9940 (Sep 14, 2022), with a median of $9.4084 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE-TIMOLOL 0.2%-0.5%, is $2.0756 per ML — about 2% below BRIMONIDINE-TIMOLOL 0.2%-0.5%.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 00781718670) is labeled by Sandoz Inc., and CMS classifies it as a generic product.